According to the Human Protein Atlas, 50% of the analysed breast cancer patients possessed elevated GRK2 or GRK5 expression16,17, whereas the latter was shown to result in even worse prognosis concerning the 5-years survival rate. Here, GRK5 is linked to breast cancer.